The Study
Anti-nuclear autoantibodies in Graves’ disease and Graves’ orbitopathy
This study looked at whether people with a certain eye problem had more of a specific antibody in their blood. It found a possible link, but it didn't prove that the antibody causes the eye problem—or that it protects against it. It just noticed a pattern in people who already had the disease.
Analysis score
Maximum 58 for a case-control study.
Where the score came from
Some people with an overactive thyroid (Graves' disease) have special antibodies called ANAs that show up in blood tests. This study looked at whether those antibodies make their eye problems worse or better.
Where does this study sit?
Reviews of RCTs (Meta-analyses)
Max 100Randomized Trials
Max 90Reviews of Cohort Studies
Max 85Cohort Studies
Max 72Reviews of Case-Control Studies
Max 63Case-Control Studies
Max 58Cross-Sectional & Case Series
Max 50Expert Opinion
Max 558 / 100
Quality score
Researchers compare people who have a condition (cases) with similar people who do not (controls), looking back in time for differences in exposure. Useful but more prone to bias.
Key takeaways
Summary
Based on the study abstract and findings.
- 1A 1.4 mm reduction in eye bulging is small but noticeable clinically — it may mean less pressure, discomfort, or visible change in appearance.
- 280% of Graves' patients had ANAs.
- 3Those with ANAs had eyes that stuck out 1.4 mm less than those without ANAs.
- 4ANAs were also less common in Graves' patients (80%) than in people with a different thyroid problem (91%).
Score breakdown, methodology, conflicts of interest, evidence analysis & raw study data
Publication
Journal
Journal of Endocrinological Investigation
Year
2022
Authors
G. Lanzolla, L. Puccinelli, M. Giudetti, S. Comi, F. Menconi, M. N. Maglionico, C. Posarelli, M. Figus, C. Marcocci, M. Marinò
Related Content
Claims (6)
In people diagnosed with Graves' disease, 80% have anti-nuclear antibodies. This rate is higher than in people without Graves' disease, but it does not differ significantly between those who have eye complications from the disease and those who do not.
Patients with Graves' disease who have anti-nuclear antibodies tend to have less eye bulging and lower disease activity scores compared to those without these antibodies.
Among people with Graves' disease, 80% test positive for anti-nuclear antibodies, while 91% of those with toxic nodular goiter test positive.
In people with Graves' disease, those who have eye complications tend to have higher levels of anti-nuclear antibodies than those without eye complications, but the difference is not statistically confirmed.
Graves' disease is a condition in which immune cells attack the thyroid gland, skin, and tissues around the eyes.
Patients with Graves' disease are more likely to have a specific nuclear speckled pattern in their anti-nuclear antibodies compared to patients with toxic nodular goiter.
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.